Exclusive interviews with leading policymakers that convey the true policy message that impacts markets.
Reporting on key macro data at the time of release.
- Emerging MarketsEmerging Markets
Real-time insight of emerging markets in CEMEA, Asia and LatAm region
- MNI ResearchMNI Research
Actionable insight on monetary policy, balance sheet and inflation with focus on global issuance. Analysis on key political risk impacting the global markets.
- About Us
Real-time Actionable Insight
Get the latest on Central Bank Policy and FX & FI Markets to help inform both your strategic and tactical decision-making.Free Access
Sign up now for free access to this content.
Please enter your details below and select your areas of interest.
Bloomberg reporting some good and some bad news about the Omicron COVID-19 variant. Reporting comments from South African epidemiologist Salim Abdool Karim on a webcast for the Caprisa charity, the scientist states that the new variant is expected to have enhanced transimissibility compared to other varians.
- Karim also expects the variant to add to already-existing pressures on hospitals in the country.
- However, he does say that he sees vaccines as continuing to protect individuals from severe symptoms of the Omicron variant.
Source: Caprisa, Salim Abdool Karim